Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000818077 | SCV000958672 | uncertain significance | Fanconi anemia | 2023-04-14 | criteria provided, single submitter | clinical testing | This variant is present in population databases (rs372710600, gnomAD 0.04%). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may create or strengthen a splice site. An algorithm developed to predict the effect of missense changes on protein structure and function (PolyPhen-2) suggests that this variant  is likely to be tolerated. ClinVar contains an entry for this variant (Variation ID: 660798). This variant has not been reported in the literature in individuals affected with FANCM-related conditions. This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 313 of the FANCM protein (p.Arg313Cys). |
Fulgent Genetics, |
RCV002478909 | SCV002790241 | uncertain significance | Spermatogenic failure 28; Premature ovarian failure 15 | 2021-12-02 | criteria provided, single submitter | clinical testing | |
Gene |
RCV003226984 | SCV003923403 | uncertain significance | not provided | 2024-05-03 | criteria provided, single submitter | clinical testing | In silico analysis indicates that this missense variant does not alter protein structure/function; Has not been previously published as pathogenic or benign to our knowledge; In silico analysis suggests this variant may impact gene splicing. In the absence of RNA/functional studies, the actual effect of this sequence change is unknown. |